Industries > Pharma > Global Neurostimulation Devices Market 2019-2029

Global Neurostimulation Devices Market 2019-2029

Spinal Cord Stimulators, Deep Brain Stimulators, Vagus Nerve Stimulators, Sacral Nerve Stimulators, Cortical Stimulators, Epilepsy, Pain Management, Hearing Loss, Incontinence, Gastroparesis, Parkinson’s Disease

PUBLISHED: 28 November 2018
PAGES: 166
PRODUCT CODE: PHA0344

Clear
WOOCS 2.2.1
SKU: PHA0344 Categories: , , Tags: , , ,

The global neurostimulation devices market will reach $13bn in 2024 and is estimated to grow at a CAGR of 13% from 2024 to 2029. In 2018, the spinal cord stimulators segment accounted for 45% of the global neurostimulation devices market.

How this report will benefit you
Read on to discover how you can exploit the future business opportunities emerging in this sector.

In this brand new 166-page report you will receive 102 charts– all unavailable elsewhere.

The 166-page report provides clear detailed insight into the neurostimulation devices market. Discover the key drivers and challenges affecting the market.

By ordering and reading our brand-new report today you stay better informed and ready to act.

Report Scope

Global Neurostimulation Devices Market from 2019-2029

• Forecast of the Global Neurostimulation Devices market by Product:
• Spinal Cord Stimulators
• Deep Brain Stimulators
• Sacral Nerve Stimulators
• Vagus Nerve Stimulators
• Cortical Stimulators
• Others

Each submarket is further segmented by regional and national market: US, Canada, Germany, France, the UK, Italy, Spain, Rest of Europe, Japan, China, India, Rest of APAC, Latin America, Middle East & Africa

• Forecast of the Global Neurostimulation Devices market by Application:
• Pain Management
• Epilepsy
• Urinary and Fecal Incontinence
• Hearing Loss
• Gastroparesis
• Parkinson’s Disease
• Others

Each submarket is further segmented by regional and national market: US, Canada, Germany, France, the UK, Italy, Spain, Rest of Europe, Japan, China, India, Rest of APAC, Latin America, Middle East & Africa

• This report provides individual revenue forecasts to 2028 for these regional and national markets:
• North America: US, Canada
• Europe: Germany, France, United Kingdom, Italy, Spain and rest of Europe
• Asia-Pacific: Japan, China, India and rest of Asia-Pacific
• RoW: Latin America, Middle East & Africa

Global Neurostimulation Devices Market 2019-2029

• Our study discusses the selected leading companies that are the major players in the neurostimulation devices market:
• Advanced Bionics
• Boston Scientific Corporation
• Cochlear ltd
• Cyberonics
• Medtronic
• Neuronetics Inc
• Nervo Corp.
• Cogentic Medical Inc
• St Jude Medical
• NDI Medical

• Our study discusses the factors that drive and restrain the neurostimulation devices market:

Visiongain’s study is intended for anyone requiring commercial analyses for the neurostimulation devices market. You find data, trends and predictions.

Buy our report today Neurostimulation Devices Market 2019-2029: Spinal Cord Stimulators, Deep Brain Stimulators, Vagus Nerve Stimulators, Sacral Nerve Stimulators, Cortical Stimulators, Epilepsy, Pain Management, Hearing Loss, Incontinence, Gastroparesis, Parkinson’s Disease

Visiongain is a trading partner with the US Federal Government
CCR Ref number: KD4R6

Download sample pages

Complete the form below to download your free sample pages for Global Neurostimulation Devices Market 2019-2029


Download sample pages

Complete the form below to download your free sample pages for Global Neurostimulation Devices Market 2019-2029


Latest Pharma news

Visiongain Publishes Food for Special Medical Purpose (FSMP) Market Report 2020-2030

The food for special medical purpose (FSMP) market growth can be attributed to the growing prevalence of metabolic diseases, growing consumer unhealthy lifestyle, and surge in demand from emerging economies such as Asia Pacific, Middle East & Africa, Latin America, and others.

12 April 2021

READ

Visiongain Publishes Cell-Based Assays Market Report to 2030

Growing incidence of chronic diseases; increasing R&D investment for drug discovery research and Growing Adoption of High-Throughput Screening Methodologies are some of the major factors that propel the market growth.

09 April 2021

READ

Visiongain Publishes Cancer Biologics Therapies Market Report 2021-2031

The main drivers for the growth include technological advancements in the development of novel biomarkers, rising preference for minimally or less invasive surgeries, increasing cancer awareness leading to growth in cancer cases, and growing disposable income in emerging economies.

06 April 2021

READ

Visiongain Publishes Artificial Intelligence (AI) in Drug Discovery Market Report 2021-2031

Factors such as increasing data volumes for analysis, quick turnaround time for the discovery and development new drug, computing power, AI also helps in targeted manufacturing and others drive the market growth.

01 April 2021

READ

Categories